OncoHealth launched by Angels-Winnie Wan, PhD, Executive Chair & CEO of OncoHealth & Don Ross, co-founder of HealthTech Capital, Member of Life Science Angels-04/12/2011 - 6:00pm

Event Information
Event Topic: 
OncoHealth launched by Angels
Event Date: 
04/12/2011 - 6:00pm
Event Location: 
Wilson Sonsini Goodrich & Rosati- 650 Page Mill Road, Palo Alto, CA
Speaker Information
Event Speaker: 
Winnie Wan, PhD, Executive Chair & CEO of OncoHealth & Don Ross, co-founder of HealthTech Capital, Member of Life Science Angels
Event Speaker Company: 
-
Event Speaker Bio: 

Winnie Wan, PhD, is the Executive Chair and CEO of OncoHealth. She is a veteran in the life science industry, with extensive experience in launching and building life science companies and has successfully commercialized disruptive technologies from inception. These technologies include the analytical systems for drug development at ForteBio, Inc., the anatomical pathology systems for cancer diagnosis at Becton Dickinson, the cell analysis systems at Guava Technologies, Inc., and the HIV drug testing model at SyStemix, Inc. Winnie held CEO or executive management positions at BEING Biopharma, Inc., ForteBio, Inc., GeneTrol BioTherapeutics, Becton Dickinson's CIS Division, Systemix, etc. She currently serves on the board of Valley Medical Foundation and Pediatric Bioscience.

She received her B.A. from Skidmore College; her Ph.D. in Biochemistry from Yale University, and her M.B.A. from Columbia University and her post-doctoral training in cell biology at Rockefeller University.

Don Ross is co-founder of HealthTech Capital, Board Director of Sand Hill Angels, and a Member of Life Science Angels. Don also is Board Director of Figure 8 Surgical and OncoHealth Corporation.

Don is active in syndications among Angel groups and early stage venture firms. Within Angel groups, he chairs screening and didactic committees. Don provides strategic guidance, operational experience, and investments to a variety of startups, which include companies in diagnostics, medical devices, eHealth, mobile, and Internet. He has a particular interest in health tech—the intersection of healthcare and information technology.

Don began working in life sciences in the early 1980s, when he developed software applications for psychological testing, health behavior change, and health monitoring. Don co-founded, built, and operated a life sciences publishing company, which was sold successfully in 2000. Specialty areas included consumer health, allergy and asthma, skin care, psychopharmacology, and kidney health. Don has startup operating experience in CEO and VP roles. He is a published author with articles, NIH-adopted literature, and college nutrition textbooks. Don is an honors graduate from UC Berkeley (architecture).

Event Details
Cost: 
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Event Details: 

OncoHealth is a protein diagnostic company dedicated to revolutionizing cervical cancer testing and other cancers associated with the Human Papilloma Virus (HPV). The current tests cannot differentiate between benign infection and pre-cancer stages. Consequently the existing tests lead to unnecessary invasive procedures and repeat testing that can be avoided by the novel test.
OncoHealth was founded at the end of 2009, right in the dearth of available funding for life science start-ups, much less for those in diagnostic businesses. Winnie Wan will talk about OncoHealth’s unusual start and business strategy that enabled the company to get its first funding from a syndicate of reputable angel groups in the Silicon Valley and other parts of the country.
Due to the latest recession, venture capital firms have become more risk averse and are investing less in early stage start-ups. More and more angel groups are now filling this void and playing a pivotal role in supporting innovation. Don Ross, an active member in the Angel community and Board director of OncoHealth, will describe how angel groups increasingly are forming syndicates with each other to provide critical funding for early stage start-ups.